
Synopsys, Inc. (SNPS)
$
463.74
-2.70 (-0.58%)
Key metrics
Financial statements
Free cash flow per share
8.1311
Market cap
86.6 Billion
Price to sales ratio
13.4733
Debt to equity
0.5483
Current ratio
1.6246
Income quality
0.7212
Average inventory
388.7 Million
ROE
0.1431
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Synopsys, Inc. provides electronic design automation software products essential for the design and testing of integrated circuits. The company reported a substantial revenue of $6,127,436,000.00 reflecting its strong market presence. It offers the Fusion Design Platform, which delivers digital design implementation solutions, and the Verification Continuum Platform, providing virtual prototyping, static and formal verification, simulation, emulation, FPGA-based prototyping, and debugging solutions. Its FPGA design products are specifically programmed for various functions. Additionally, the company offers intellectual property (IP) solutions across several applications, including USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy. Other IP offerings cover analog needs such as data converters and audio codecs, as well as system-on-chip (SoC) infrastructure IP, datapath building blocks, and verification IP products. The company also specializes in mathematical components, floating-point elements, and the Arm AMBA interconnect fabric and associated peripherals. Furthermore, Synopsys provides logic libraries, embedded memories, configurable processor cores, and application-specific instruction-set processor tools for embedded applications, as well as IP subsystems for audio, sensor, and data fusion functionalities, along with security IP solutions. It also offers Platform Architect solutions for SoC architecture analysis and optimization, virtual prototyping tools, and HAPS FPGA-based prototyping systems, alongside various tools involved in designing optical systems and photonic devices. The operating income ratio is 0.22 indicating the company's operational profitability margin. The cost of revenue for the company is $1,245,289,000.00 showcasing its production and operational expenses. Moreover, the income before tax ratio is 0.25 reflecting the pre-tax margin, and the company's stock is identified with the symbol 'SNPS' in the market. The stock is priced at $495.50 positioning it in the higher-end market, and it has a high average trading volume of 3,173,104.00 indicating strong liquidity. With a large market capitalization of $86,136,286,772.00 Synopsys is a dominant player in the electronics industry, contributing significantly to the overall market landscape. It belongs to the Technology sector, driving innovation and growth, reinforcing its status as a key player in the Software - Infrastructure industry.
Investing in Synopsys, Inc. (SNPS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict Synopsys, Inc. stock to fluctuate between $365.74 (low) and $651.73 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-12-04, Synopsys, Inc.'s market cap is $86,136,286,772, based on 185,742,629 outstanding shares.
Compared to Nvidia Corp, Synopsys, Inc. has a Lower Market-Cap, indicating a difference in performance.
To buy Synopsys, Inc. (SNPS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for SNPS. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Synopsys, Inc.'s last stock split was 2:1 on 2003-09-24.
Revenue: $6,127,436,000 | EPS: $14.78 | Growth: 82.92%.
Visit https://www.synopsys.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $651.73 (2025-07-30) | All-time low: $255.02 (2022-05-12).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

newsfilecorp.com
New York, New York--(Newsfile Corp. - December 4, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.

prnewswire.com
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Synopsys To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Synopsys between December 4, 2024 and September 9, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 4, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ: SNPS) and reminds investors of the December 30, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

prnewswire.com
LOS ANGELES , Dec. 4, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Synopsys, Inc. ("Synopsys " or "the Company") (NASDAQ: SNPS ) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SNPS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

seekingalpha.com
Synopsys is foundational to the semiconductor industry, providing essential EDA software and IP that underpin modern chip design and manufacturing. The company boasts a dominant market position, high switching costs, and tight integration with foundries, ensuring recurring and resilient revenue streams. The $35bn Ansys acquisition transforms the firm into an end-to-end design provider, expanding its TAM to $31bn and deepening customer lock-in via integrated simulation workflows.

seekingalpha.com
Synopsys is rated Hold with a $475 price target, reflecting a 10% upside and market-like performance amid premium valuation and bottom-line headwinds. SNPS trades at a 32x forward P/E, a significant premium to peers, despite a 24% year-over-year EPS decline and mixed segment results. Core EDA business drives growth, but revenue concentration, margin erosion, and heavy leverage present risks if AI-driven demand or profitability falters.

newsfilecorp.com
New York, New York--(Newsfile Corp. - December 3, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the "Class Period"), of the important December 30, 2025 lead plaintiff deadline. SO WHAT: If you purchased Synopsys securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com
New York, New York--(Newsfile Corp. - December 3, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.

globenewswire.com
LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 30, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS) securities between December 4, 2024 and September 9, 2025, inclusive (the “Class Period”).

globenewswire.com
NEW YORK and NEW ORLEANS, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until December 30, 2025 to file lead plaintiff applications in securities class action lawsuits against Synopsys, Inc. (“Synopsys” or the “Company”) (NasdaqGS: SNPS), if they purchased or otherwise acquired the Company's securities between December 4, 2024 and September 9, 2025, inclusive (the “Class Period”) and/or purchased or otherwise acquired Synopsys common stock in exchange for their shares of Ansys, Inc. (“Ansys”) common stock in the acquisition of Ansys. These actions are pending in the United States District Court for the Northern District of California

newsfilecorp.com
New York, New York--(Newsfile Corp. - December 2, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the "Class Period"), of the important December 30, 2025 lead plaintiff deadline. SO WHAT: If you purchased Synopsys securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
See all news